HILDEN , Germany and GERMANTOWN, Maryland , December 4, 2014 /PRNewswire/ --
New molecular diagnostic test detects but does not differentiate all existing strains of Ebola virus Partnership with altona Diagnostics adds to portfolio of QIAGEN products already in use outside the United States by research and clinical laboratories for Ebola diagnostics and research QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it will offer global distribution of the altona Diagnostics RealStar ® Ebolavirus RT-PCR Kit 1.0 after the U.S. Food and Drug Administration amended, on November 26, 2014 to permit authorized distribution and use in US and certain non-US laboratories, an Emergency Use Authorization (EUA) originally issued on November 10, 2014 , for this kit.
NOOK Media LLC, a subsidiary of Barnes & Noble, Inc. (NYSE:BKS) ,
the leading retailer of content, digital media and educational products,
today announced that NOOK Press ( www.nookpress.com )
has partnered with The Bookseller on a new preview section for
self-published authors in the UK named ‘ The Bookseller’s Independent
NOOK Press will sponsor the new section and will be the exclusive source
of self-published titles for preview consideration through April 2015.
Inc. (NASDAQ:ADTN), a leading provider of next-generation networking
solutions, today announced as part of its Enabling Communities,
Connecting Lives program, that Jackson Energy Authority (JEA) has
selected ADTRAN’s advanced Gigabit service architecture to deliver
next-generation broadband across one of the nation’s largest public
Fiber-to-the-Home (FTTH) networks.
Squibb Company (NYSE:BMY) today announced that the European
Medicines Agency (EMA) has validated for review the Marketing
Authorization Application (MAA) for nivolumab in non-small cell lung
cancer (NSCLC) – the first completed regulatory submission for a PD-1
immune checkpoint inhibitor in this tumor type.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.